BIPOLAR TRANSURETHRAL RESECTION OF THE PROSTATE – THE MODERN APPROACH
Keywords:
Bipolar transurethral resection, Prostate, Benign prostatic hyperplasia, CRISTIAN PERSUAbstract
Benign prostatic hyperplasia (BPH) is a common condition of the aging male, affecting a significant percentage of the population. The last decades were marked by a continuous evolution of the surgical treatment for BPH, with newer technologies promising less invasive approaches, better outcomes, and fewer complications. Bipolar transurethral resection (B-TURP) is the latest development in the field and it already proved its superiority over its predecessors. Our paper aims to review the technology behind this surgical technique, its main advantages, and the limits of the method. We highlight the indications, main complications, and results of this surgical technique while comparing the data with the “classical” TURP. We conclude that the advances made by technology bring a real benefit both for the patients and medical professionals involved in the treatment of BPH.
References
(1) D. Skinder, I. Zacharia, J. Studin, J. Covino, Benign prostatic hyperplasia: a clinical review. JAAPA 29, pp. 19-23 (2016)
(2) S.A. Kaplan, E. O’Neill, R. Lowe, M. Hanson, A.G. Meehan, Prevalence of low testosterone in aging men with benign prostatic hyperplasia: Data from the Proscar Long-term Efficacy and Safety Study (PLESS) Aging Male, 16, pp. 48-51 (2013).
(3) J.K. Parsons, K. Palazzi-Churas, J. Bergstrom, E. Barrett-Connor, Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community-dwelling men: The Rancho Bernardo Study, J Urol, 184, pp. 1040-1044 (2010).
(4) J.K. Parsons, A.V. Sarma, K. McVary, J.T. Wei, Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms, and future directions, J. Urol., 189, pp. 102-106 (2013).
(5) Sausville J, Naslund M., Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians, Int. J. Clin. Pract. 64, 13, pp. 1740-1745 (2010).
(6) * EAU Guidelines, Edn., presented at the EAU Annual Congress Amsterdam (2020).
(7) A.V. Sarma, J.T. Wei, Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med., 367, 3, pp. 248–257.
(8) Y. Dong, L. Hao, Z. Shi, G. Wang, Z. Zhang, C. Han, Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis. Urol Int., 91, 1, pp. 10-18 (2013).
(9) D.S. Engeler, C. Schwab, M. Neyer, T. Grün, A. Reissigl, H.P. Schmid, Bipolar versus monopolar TURP: a prospective controlled study at two urology centers, Prostate Cancer Prostatic Dis. 13, 3, pp. 285-291 (2010).
(10) M.I. Omar, T.B. Lam, C.E. Alexander, J. Graham, C. Mamoulakis, M. Imamura, S. Maclennan, F. Stewart, J. N'dow, Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int., Epub 2013 Oct 24. PMID: 24053602, 113, 1, pp. 24-35 (2014).
(11) V.K. Madduri, M.K. Bera, D.K. Pal, Monopolar versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario, Urol. Ann., 8, 3, pp. 291-296 (2016).
(12) X. Huang, X.H. Wang, H.P. Wang, L.J. Qu, Comparison of the microvessel diameter of hyperplastic prostate and the coagulation depth achieved with mono- and bipolar transurethral resection of the prostate. A pilot study on hemostatic capability, Scand. J. Urol. Nephrol., 42, 3, pp. 265-268 (2008).
(13) A. Corona, S. Serra, M. Deplano, A. De Lisa, La resezione endoscopica con resettore bipolare gyrus nelle ghiandole di volume superiore a 80 ml: nostra esperienza a 12 mesi di follow-up [Endoscopic prostate resection by bipolar gyrus resector for prostates over 80 ml: our experience after a 12-month follow-up], Urologia, 30,79, Suppl. 19, pp. 30-36 (2012).
(14) M.A. Egui-Rojo, L. Redón-Gálvez, M. Álvarez-Ardura, H. Otaola-Arca, A. Páez-Borda, Comparación entre resección monopolar vs. resección bipolar transuretrales de próstata y su impacto sobre la función sexual [Comparison of monopolar versus bipolar transurethral resection of the prostate: Evaluation of the impact on sexual function]. Rev. Int. Androl., 18, 2, pp. 43-49 (2020).
(15) A. El-Assmy, A. Elshal, R. Mekkawy, H. El-Kappany, E. Ibrahiem, Erectile and ejaculatory functions changes following bipolar versus monopolar transurethral resection of the prostate: a prospective randomized study, International Urology, and Nephrology. 50, pp. 1-8, (2018).
(16) E.M.A. ElMalik, A.I.A. Ibrahim, A.M. Gahl, M.S.M. Saad, Y.B. Bahar, Risk Factors in Prostatectomy Bleeding: Preoperative Urinary Infection is the only Reversible Factor, Eur. Urol., 37, pp. 199-204 (2000).
(17) B.M. Shrestha, K. Prasopshanti, S.S. Matanhelia, W.B. Peeling, Blood loss during and after transurethral resection of the prostate: a prospective study, Kathmandu Univ. Med. J. (KUMJ), 6, 23, pp. 329-334 (2008).
(18) C.H. Yee, J.H. Wong, P.K. Chiu, et al., Secondary hemorrhage after bipolar transurethral resection and vaporization of the prostate, Urol. Ann., 8, 4, pp. 458-463 (2016).
(19) K. Raghuvanshi et al., Comparative assessment of monopolar versus bipolar transurethral resection of the prostate for the management of benign prostatic enlargement, Urological Science, 30, 6, pp. 262 (2019).
(20) M.I. Omar, T.B. Lam, C.E. Alexander, J. Graham, C. Mamoulakis, M. Imamura, Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP), BJU Int., 113, pp. 24-35 (2014).
(21) J. Rassweiler, D. Teber, R. Kuntz, R. Hofmann, Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention, Eur. Urol., 50, 5, pp. 969-979, discussion 980 (2006).
(22) S. Mukherjee, R.K. Sinha, N. Ghosh, D. Karmakar, Urinary incontinence following transurethral prostatectomy presenting as self-inflicted penile gangrene, BMJ Case Rep., 2015, bcr2014206902 (2015 Jun 8).
(23) H.E. Foster, M.J. Barry, P. Dahm, M.C. Gandhi, S.A. Kaplan, T.S. Kohler, L.B. Lerner, D.J. Lightner, J.K. Parsons, C.G. Roehrborn, C. Welliver, T.J. Wilt, K.T, McVary, Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline, J. Urol., 200, 3, pp. 612-619 (2018).
(24) A. Taher, Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors, World J. Urol., 22, 6, pp.457-460 (2004).
(25) M. Muntener, S. Aellig, R. Kuettel, C. Gehrlach, T. Sulser, R.T Strebel, Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome, Eur. Urol., 52, 2, pp. 510-515 (2007).
(26) B.N. Kumar, A. Srivastava, T. Sinha, Urethral stricture after bipolar transurethral resection of the prostate – truth vs hype: A randomized controlled trial, Indian J. Urol., 35, 1, pp. 41-47 (2019).
(27) A.A. Zamel, A.I. Kassem, T.Z. Orban, I.R. Saad, A.S. Bedair, Urethral stricture disease after bipolar prostatectomy: Is it a concern? Afr. J. Urol., 24, pp. 24–27 (2018).
(28) K. Komura, T. Inamoto, T. Takai, et al., Urethral stricture incidence and bipolar TURP, BJU Int., 115, pp. 644-652 (2015).
(29) J. Wen, B. Nørby, P.J.S. Osther, Bladder Neck Contracture after Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia Treated with a Thermo-Expandable Metal Stent (Memokath® 045), Case Rep. Urol., 2018, 2439421 (2018).
(30) A. Grechenkov, R. Sukhanov, E. Bezrukov, et al., Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia, Urologia J., 85, 4, pp. 150-157 (2018).
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Romanian Journal of Technical Sciences, Electrical and Energy Series
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
